Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Delcath Systems, Inc. (DCTH)

3.2   0.1 (3.23%) 10-01 11:03
Open: 3.145 Pre. Close: 3.1
High: 3.33 Low: 3.145
Volume: 16,229 Market Cap: 28(M)
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.33 - 3.35 3.35 - 3.36
Low: 3.11 - 3.13 3.13 - 3.14
Close: 3.18 - 3.2 3.2 - 3.22

Technical analysis

as of: 2022-09-30 4:27:23 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.57     One year: 5.25
Support: Support1: 2.97    Support2: 2.47
Resistance: Resistance1: 3.91    Resistance2: 4.5
Pivot: 3.55
Moving Average: MA(5): 3.15     MA(20): 3.71
MA(100): 4.1     MA(250): 6.24
MACD: MACD(12,26): -0.3     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 11.5     %D(3): 12.1
RSI: RSI(14): 31.3
52-week: High: 11.95  Low: 2.97
Average Vol(K): 3-Month: 22 (K)  10-Days: 17 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ DCTH ] has closed above bottom band by 25.7%. Bollinger Bands are 65.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Headline News

Mon, 08 Aug 2022
Delcath Systems, Inc. (DCTH) CEO Gerard Michel on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha

Fri, 05 Aug 2022
Results of a Multicenter Study on Delcath's CHEMOSAT® Hepatic Delivery System Published in Cardiovascular and Interventional Radiology - PR Newswire

Wed, 20 Jul 2022
Delcath Systems Closes Private Placement of $5.0 Million - PR Newswire

Mon, 18 Jul 2022
Delcath Systems Announces Private Placement of $5.0 Million - Yahoo Finance

Tue, 17 May 2022
Delcath Systems: Revisiting A $5 Lottery Ticket (NASDAQ:DCTH) - Seeking Alpha

Tue, 10 May 2022
Delcath Systems Reports First Quarter 2022 Results and Provides Business Update - GlobeNewswire

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 9 (M)
Shares Float 8 (M)
% Held by Insiders 2.4 (%)
% Held by Institutions 19.3 (%)
Shares Short 200 (K)
Shares Short P.Month 248 (K)

Stock Financials

EPS -3.59
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.37
Profit Margin (%) 0
Operating Margin (%) -732.8
Return on Assets (ttm) -75.8
Return on Equity (ttm) -492.7
Qtrly Rev. Growth 48.7
Gross Profit (p.s.) 0.33
Sales Per Share 0.44
EBITDA (p.s.) -3.24
Qtrly Earnings Growth 0
Operating Cash Flow -23 (M)
Levered Free Cash Flow -14 (M)

Stock Valuations

PE Ratio -0.9
PEG Ratio -0.1
Price to Book value -8.89
Price to Sales 7.22
Price to Cash Flow -1.18

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2019-12-23
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.